These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 16098719)

  • 1. Design, synthesis and bioactions of novel stable mimetics of lipoxins and aspirin-triggered lipoxins.
    Petasis NA; Akritopoulou-Zanze I; Fokin VV; Bernasconi G; Keledjian R; Yang R; Uddin J; Nagulapalli KC; Serhan CN
    Prostaglandins Leukot Essent Fatty Acids; 2005; 73(3-4):301-21. PubMed ID: 16098719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipoxins and aspirin-triggered 15-epi-lipoxins are the first lipid mediators of endogenous anti-inflammation and resolution.
    Serhan CN
    Prostaglandins Leukot Essent Fatty Acids; 2005; 73(3-4):141-62. PubMed ID: 16005201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel endogenous small molecules as the checkpoint controllers in inflammation and resolution: entrée for resoleomics.
    Serhan CN; Chiang N
    Rheum Dis Clin North Am; 2004 Feb; 30(1):69-95. PubMed ID: 15061569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-inflammatory circuitry: lipoxin, aspirin-triggered lipoxins and their receptor ALX.
    Chiang N; Arita M; Serhan CN
    Prostaglandins Leukot Essent Fatty Acids; 2005; 73(3-4):163-77. PubMed ID: 16125378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipoxins: pro-resolution lipid mediators in intestinal inflammation.
    Goh J; Godson C; Brady HR; Macmathuna P
    Gastroenterology; 2003 Apr; 124(4):1043-54. PubMed ID: 12671901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipoxins and aspirin-triggered 15-epi-lipoxins are endogenous components of antiinflammation: emergence of the counterregulatory side.
    Serhan CN
    Arch Immunol Ther Exp (Warsz); 2001; 49(3):177-88. PubMed ID: 11478391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Lipoxins--new view on old mediators carrying potent anti-inflammatory action].
    Jarmakowska K; Kuna P
    Pol Merkur Lekarski; 2005 May; 18(107):491-5. PubMed ID: 16161940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipid-derived mediators in endogenous anti-inflammation and resolution: lipoxins and aspirin-triggered 15-epi-lipoxins.
    Serhan CN; Chiang N
    ScientificWorldJournal; 2002 Jan; 2():169-204. PubMed ID: 12806051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel omega -- 3-derived local mediators in anti-inflammation and resolution.
    Serhan CN
    Pharmacol Ther; 2005 Jan; 105(1):7-21. PubMed ID: 15626453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipoxins: novel anti-inflammatory therapeutics?
    Godson C; Brady HR
    Curr Opin Investig Drugs; 2000 Nov; 1(3):380-5. PubMed ID: 11249723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipoxin analogs: novel anti-inflammatory mediators.
    Gewirtz A
    Curr Opin Investig Drugs; 2005 Nov; 6(11):1112-5. PubMed ID: 16312131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver: the formation and actions of aspirin-triggered lipoxins.
    Clària J; Planagumà A
    Prostaglandins Leukot Essent Fatty Acids; 2005; 73(3-4):277-82. PubMed ID: 16006110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipoxins and aspirin-triggered lipoxins in neutrophil adhesion and signal transduction.
    Filep JG; Khreiss T; József L
    Prostaglandins Leukot Essent Fatty Acids; 2005; 73(3-4):257-62. PubMed ID: 15979865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipoxins and new lipid mediators in the resolution of inflammation.
    Schwab JM; Serhan CN
    Curr Opin Pharmacol; 2006 Aug; 6(4):414-20. PubMed ID: 16750421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipoxins: regulators of resolution.
    Ryan A; Godson C
    Curr Opin Pharmacol; 2010 Apr; 10(2):166-72. PubMed ID: 20226737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The lipoxin receptor ALX: potent ligand-specific and stereoselective actions in vivo.
    Chiang N; Serhan CN; Dahlén SE; Drazen JM; Hay DW; Rovati GE; Shimizu T; Yokomizo T; Brink C
    Pharmacol Rev; 2006 Sep; 58(3):463-87. PubMed ID: 16968948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiogenesis and lipoxins.
    Fierro IM
    Prostaglandins Leukot Essent Fatty Acids; 2005; 73(3-4):271-5. PubMed ID: 15982864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ATLa, an aspirin-triggered lipoxin A4 synthetic analog, prevents the inflammatory and fibrotic effects of bleomycin-induced pulmonary fibrosis.
    Martins V; Valença SS; Farias-Filho FA; Molinaro R; Simões RL; Ferreira TP; e Silva PM; Hogaboam CM; Kunkel SL; Fierro IM; Canetti C; Benjamim CF
    J Immunol; 2009 May; 182(9):5374-81. PubMed ID: 19380784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipoxins and aspirin-triggered lipoxins in resolution of inflammation.
    Romano M; Cianci E; Simiele F; Recchiuti A
    Eur J Pharmacol; 2015 Aug; 760():49-63. PubMed ID: 25895638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipoxins and novel aspirin-triggered 15-epi-lipoxins (ATL): a jungle of cell-cell interactions or a therapeutic opportunity?
    Serhan CN
    Prostaglandins; 1997 Feb; 53(2):107-37. PubMed ID: 9112289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.